Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways
Xinyan Wu(Shandong University of Technology), Akhilesh Pandey(Mayo Clinic), Pamela Leal(Universidad de La Frontera), Jun Zhong(Guangzhou University of Chinese Medicine), Mustafa A. Barbhuiya(Johns Hopkins Medicine), Juan Carlos Roa(Pontificia Universidad Católica de Chile), Raghothama Chaerkady(Johns Hopkins University), Mary Jo Fackler(Sidney Kimmel Comprehensive Cancer Center), Vered Stearns(Johns Hopkins University), Cynthia A. Zahnow(Johns Hopkins University), Vanessa F. Merino(University of Maryland, Baltimore), Santosh Renuse(AstraZeneca (United States)), Min‐Sik Kim(Daegu Gyeongbuk Institute of Science and Technology), Manoj Kumar Kashyap(Amity University), Binyun Ma(University of Southern California), Saraswati Sukumar(Johns Hopkins University), Christine Jelinek(Johns Hopkins University), Ren Liu(University of Southern California), Zhen Zhang(Fudan University Shanghai Cancer Center), Yi Yang(Shenyang Pharmaceutical University), Lily Chen(Huaqiao University), Arivusudar Marimuthu(Institute of Bioinformatics), Parkash S. Gill(University of Southern California), Nandini A. Sahasrabuddhe(Institute of Bioinformatics), Edward Gabrielson(Bloomberg (United States)), Muhammad Saddiq Zahari(Johns Hopkins University)
Cited by 67
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
A draft map of the human proteome
|Nature|2014|2.3k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k